Phase I/IIa Study of Genetically Engineered NY-ESO-1 SPEAR T-Cells Administered Following Autologous Stem Cell Transplant in HLA-a*02+ Patients with Advanced Multiple Myeloma: Long Term Follow-up (NCT01352286)
Autor: | Rapoport, Aaron P., Stadtmauer, Edward A *, Chagin, Karen *, Faitg, Thomas *, Iyengar, Malini *, Trivedi, Trupti *, Norry, Elliot *, Holdich, Tom *, Binder-Scholl, Gwendolyn *, Amado, Rafael *, Fang, Frank * |
---|---|
Zdroj: | In Blood 8 December 2017 130 Supplement 1:845-845 |
Databáze: | ScienceDirect |
Externí odkaz: |